Norway · Delayed Price · Currency is NOK Medistim ASA Statistics
Total Valuation
Medistim ASA has a market cap or net worth of NOK 4.11 billion. The enterprise value is 3.95 billion.
| Market Cap | 4.11B |
| Enterprise Value | 3.95B |
Important Dates
The last earnings date was Tuesday, April 14, 2026.
| Earnings Date | Apr 14, 2026 |
| Ex-Dividend Date | May 7, 2026 |
Share Statistics
Medistim ASA has 18.28 million shares outstanding. The number of shares has decreased by -0.21% in one year.
| Current Share Class | 18.28M |
| Shares Outstanding | 18.28M |
| Shares Change (YoY) | -0.21% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 2.94% |
| Owned by Institutions (%) | 83.67% |
| Float | 12.54M |
Valuation Ratios
The trailing PE ratio is 25.83 and the forward PE ratio is 26.50.
| PE Ratio | 25.83 |
| Forward PE | 26.50 |
| PS Ratio | 5.88 |
| PB Ratio | 8.78 |
| P/TBV Ratio | 10.76 |
| P/FCF Ratio | 22.65 |
| P/OCF Ratio | 21.99 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.62, with an EV/FCF ratio of 21.76.
| EV / Earnings | 24.82 |
| EV / Sales | 5.65 |
| EV / EBITDA | 18.62 |
| EV / EBIT | 20.14 |
| EV / FCF | 21.76 |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.11.
| Current Ratio | 3.34 |
| Quick Ratio | 2.16 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.23 |
| Debt / FCF | 0.27 |
| Interest Coverage | 360.66 |
Financial Efficiency
Return on equity (ROE) is 35.18% and return on invested capital (ROIC) is 51.38%.
| Return on Equity (ROE) | 35.18% |
| Return on Assets (ROA) | 19.85% |
| Return on Invested Capital (ROIC) | 51.38% |
| Return on Capital Employed (ROCE) | 37.92% |
| Weighted Average Cost of Capital (WACC) | 9.77% |
| Revenue Per Employee | 4.40M |
| Profits Per Employee | 1.00M |
| Employee Count | 154 |
| Asset Turnover | 1.13 |
| Inventory Turnover | 0.80 |
Taxes
In the past 12 months, Medistim ASA has paid 47.64 million in taxes.
| Income Tax | 47.64M |
| Effective Tax Rate | 23.03% |
Stock Price Statistics
The stock price has increased by +38.89% in the last 52 weeks. The beta is 1.02, so Medistim ASA's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | +38.89% |
| 50-Day Moving Average | 215.46 |
| 200-Day Moving Average | 235.75 |
| Relative Strength Index (RSI) | 51.26 |
| Average Volume (20 Days) | 20,626 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medistim ASA had revenue of NOK 699.77 million and earned 159.21 million in profits. Earnings per share was 8.71.
| Revenue | 699.77M |
| Gross Profit | 571.59M |
| Operating Income | 196.20M |
| Pretax Income | 206.85M |
| Net Income | 159.21M |
| EBITDA | 203.40M |
| EBIT | 196.20M |
| Earnings Per Share (EPS) | 8.71 |
Balance Sheet
The company has 212.09 million in cash and 49.27 million in debt, with a net cash position of 162.82 million or 8.91 per share.
| Cash & Cash Equivalents | 212.09M |
| Total Debt | 49.27M |
| Net Cash | 162.82M |
| Net Cash Per Share | 8.91 |
| Equity (Book Value) | 468.41M |
| Book Value Per Share | 25.62 |
| Working Capital | 334.51M |
Cash Flow
In the last 12 months, operating cash flow was 187.08 million and capital expenditures -5.49 million, giving a free cash flow of 181.59 million.
| Operating Cash Flow | 187.08M |
| Capital Expenditures | -5.49M |
| Depreciation & Amortization | 7.20M |
| Net Borrowing | -9.36M |
| Free Cash Flow | 181.59M |
| FCF Per Share | 9.93 |
Margins
Gross margin is 81.68%, with operating and profit margins of 28.04% and 22.75%.
| Gross Margin | 81.68% |
| Operating Margin | 28.04% |
| Pretax Margin | 29.56% |
| Profit Margin | 22.75% |
| EBITDA Margin | 29.07% |
| EBIT Margin | 28.04% |
| FCF Margin | 25.95% |
Dividends & Yields
This stock pays an annual dividend of 8.00, which amounts to a dividend yield of 3.48%.
| Dividend Per Share | 8.00 |
| Dividend Yield | 3.48% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 68.76% |
| Buyback Yield | 0.21% |
| Shareholder Yield | 3.69% |
| Earnings Yield | 3.87% |
| FCF Yield | 4.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medistim ASA has an Altman Z-Score of 15.37 and a Piotroski F-Score of 6.
| Altman Z-Score | 15.37 |
| Piotroski F-Score | 6 |